3 Stocks Pushing The Health Services Industry Lower

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

One out of the three major indices are trading lower today with the Dow Jones Industrial Average ( ^DJI) trading up 40 points (0.3%) at 15,878 as of Tuesday, Jan. 28, 2014, 11:55 AM ET. The NYSE advances/declines ratio sits at 1,973 issues advancing vs. 972 declining with 141 unchanged.

The Health Services industry currently sits up 0.6% versus the S&P 500, which is up 0.3%. Top gainers within the industry include Waters Corporation ( WAT), up 7.0%, PerkinElmer ( PKI), up 3.1%, Align Technology ( ALGN), up 2.7%, Grifols ( GRFS), up 2.1% and Mettler-Toledo International ( MTD), up 1.9%.

TheStreet would like to highlight 3 stocks pushing the industry lower today:

3. Cigna ( CI) is one of the companies pushing the Health Services industry lower today. As of noon trading, Cigna is down $0.60 (-0.7%) to $86.40 on light volume. Thus far, 392,191 shares of Cigna exchanged hands as compared to its average daily volume of 1.4 million shares. The stock has ranged in price between $86.36-$87.48 after having opened the day at $86.96 as compared to the previous trading day's close of $87.00.

Cigna Corporation, a health services organization, provides insurance and related products and services in the United States and internationally. Cigna has a market cap of $24.0 billion and is part of the health care sector. The company has a P/E ratio of 13.2, below the S&P 500 P/E ratio of 17.7. Shares are down 0.6% year-to-date as of the close of trading on Monday. Currently there are 8 analysts that rate Cigna a buy, no analysts rate it a sell, and 6 rate it a hold.

TheStreet Ratings rates Cigna as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, growth in earnings per share and increase in net income. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Cigna Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

2. As of noon trading, Quest Diagnostics ( DGX) is down $0.52 (-1.0%) to $53.24 on average volume. Thus far, 1.7 million shares of Quest Diagnostics exchanged hands as compared to its average daily volume of 2.4 million shares. The stock has ranged in price between $53.01-$53.72 after having opened the day at $53.61 as compared to the previous trading day's close of $53.76.

Quest Diagnostics Incorporated provides diagnostic testing information services in the United States and internationally. The company operates in two businesses, Diagnostic Information Services and Diagnostic Solutions. Quest Diagnostics has a market cap of $7.8 billion and is part of the health care sector. The company has a P/E ratio of 10.3, below the S&P 500 P/E ratio of 17.7. Shares are up 0.4% year-to-date as of the close of trading on Monday. Currently there are 3 analysts that rate Quest Diagnostics a buy, 4 analysts rate it a sell, and 11 rate it a hold.

TheStreet Ratings rates Quest Diagnostics as a buy. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, increase in net income, notable return on equity, expanding profit margins and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Quest Diagnostics Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

1. As of noon trading, WellPoint ( WLP) is down $0.49 (-0.6%) to $84.40 on average volume. Thus far, 965,341 shares of WellPoint exchanged hands as compared to its average daily volume of 2.2 million shares. The stock has ranged in price between $84.30-$85.49 after having opened the day at $84.90 as compared to the previous trading day's close of $84.89.

WellPoint, Inc., a health benefits company, through its subsidiaries, offers network-based managed care plans to large and small employer, individual, Medicaid, and senior markets in the United States. The company operates through three segments: Commercial, Consumer, and Other. WellPoint has a market cap of $24.9 billion and is part of the health care sector. The company has a P/E ratio of 9.1, below the S&P 500 P/E ratio of 17.7. Shares are down 8.1% year-to-date as of the close of trading on Monday. Currently there are 5 analysts that rate WellPoint a buy, no analysts rate it a sell, and 11 rate it a hold.

TheStreet Ratings rates WellPoint as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, attractive valuation levels and good cash flow from operations. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full WellPoint Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you are interested in one of these 5 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).
null

If you liked this article you might like

Snap and Coca-Cola Are Among 16 Stocks That Are Ready to Change Direction

Snap and Coca-Cola Are Among 16 Stocks That Are Ready to Change Direction

The Really Big Money Rushes to Super Bowl

The Really Big Money Rushes to Super Bowl

Big Pharma and the Sellers of Its Products Now Have a Problem

Big Pharma and the Sellers of Its Products Now Have a Problem

Managed Care Stocks Thrashed on Amazon News but Could Be Buying Opportunity

Managed Care Stocks Thrashed on Amazon News but Could Be Buying Opportunity

Can Buffett and a Couple of Rich Celebrity CEOs Really Fix Healthcare?

Can Buffett and a Couple of Rich Celebrity CEOs Really Fix Healthcare?